Pharmacokinetics and tolerability of sustained-release muco-adhesive fentanyl [Fentanyl Lauriad] for the treatment of chronic cancer pain

Trial Profile

Pharmacokinetics and tolerability of sustained-release muco-adhesive fentanyl [Fentanyl Lauriad] for the treatment of chronic cancer pain

Completed
Phase of Trial: Phase I

Latest Information Update: 11 Mar 2010

At a glance

  • Drugs Fentanyl (Primary)
  • Indications Cancer pain
  • Focus Pharmacokinetics
  • Most Recent Events

    • 04 Aug 2009 New trial record.
    • 29 Jul 2009 Recruitment is expected to begin by the end of 2009, according to a BioAlliance Pharma media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top